Study on THC, Eye Movement, and Thinking Skills

This study is looking at how different amounts of cannabis (with 0, 5, or 30 mg of THC) affect your eye movements and thinking skills. Researchers want to see if these effects are different for people who use cannabis often compared to those who use it rarely. They also want to find out if changes in eye movement can accurately show when someone is impaired by THC. You can join if you are a healthy adult between 18 and 60 years old. You must either use cannabis infrequently (at least once in the past year, with a negative THC urine test at the start) or frequently (more than 5 days a week for over a year, with a positive THC urine test at the start). The study aims to understand how THC and how often you use cannabis impact your eye movements and sustained attention (your ability to focus). The current status of this study is unclear.

Study design
This is a double-blind, placebo-controlled study with all participants trying different doses of THC. It plans to include 40 participants.
What's involved
You will inhale cannabis with different THC levels. Your eye movements and reaction times will be measured before and after taking cannabis, and again at 2 and 4 hours later.
Compensation
Not stated in the trial record.
Follow-up
Your performance will be measured up to 4 hours after taking cannabis.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06351540

Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance

Not Yet Recruiting
PHASE1Ages 18–60InterventionalBasic science
Johns Hopkins University
~40 participants
Updated 2026-08-14 on ClinicalTrials.gov
What's tested:Cannabis

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Commission Errors
Measured over pre-administration, post-administration, 2, 4 hours
+4 more outcomes measured
Cannabis Use
Impaired Driving
Cognitive Impairment
1 sites across 1 states
Maryland1
  • Dustin C Lee, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

(a) infrequent cannabis use defined as at least one reported use in the past year with a negative THC urine toxicology at baseline, or
(b) report frequent cannabis use defined as \> 5 days per week for \> 1 year with a positive THC urine toxicology at baseline.

Exclusion

(1) meet DSM-V criteria for substance use disorders other than tobacco, cannabis, or caffeine,
(2) are currently receiving or interested in immediately receiving behavioral treatment or medication for cannabis cessation,
(3) current use of any medications that could affect study outcomes,
(4) test positive for drugs of abuse (other than cannabis) and/or breath alcohol test at study admission,
(5) have a current physical or mental illness judged by the study team to negatively impact participant safety or scientific integrity,
(6) are currently pregnant, planning to become pregnant in the next three months or are currently breastfeeding,
(7) have a history of clinically significant cardiac arrhythmias or vasospastic disease (e.g. Prinzmetal's angina), or (8) are currently enrolled in another clinical trial or have received any drug as part of a research study within 30 days of study participation.
  • Commission Errorspre-administration, post-administration, 2, 4 hours

    The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Commission errors is measured by calculating the number of trials participants incorrectly push the spacebar in the presence of "X" stimulus.

  • Omission Errorspre-administration, post-administration, 2, 4 hours

    The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Omission errors is measured by calculating the number of trials participants fail to push the spacebar in the presence of a letter that is not an "X" stimulus.

  • Reaction Timepre-administration, post-administration, 2, 4 hours

    The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Reaction time is measured by calculating the duration between the presentation of a letter other than "X", and the correct response of a spacebar push.

  • Reaction Time Standard Errorpre-administration, post-administration, 2, 4 hours

    The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Reaction time standard error is measured by calculating the standard error of the mean of the reaction time.

  • Visuomotor Indexpre-administration, post-administration, 2, 4 hours

    The visuomotor index score is calculated by mathematically integrating five measures of oculomotor fixation performance and two measures of accuracy into a single score during fixation and accuracy tasks, respectively. Test of visual fixation to measure microsaccades, spontaneous nystagmus, and gaze-evoked nystagmus.